Larvol Delta - ABVC-BioPharma-Executes-a-Global-Licensing-Denitive-Agreement-for-the-Treatment-of-NSCLC-Expecting-Aggregate-Income-of-1375M-and-Royalties-of-up-to-1250M

RGC-1501 - ABVC BioPharma, Rgene Corp

https://www.globenewswire.com/news-release/2024/04/17/2864586/0/en/ABVC-BioPharma-Executes-a-Global-Licensing-Definitive-Agreement-for-the-Treatment-of-NSCLC-Expecting-Aggregate-Income-of-13-75M-and-Royalties-of-up-to-12-50M.html

Apr 17, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next